- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Earlier today Americans for Safe Access (ASA) submitted expanded testimony to the DC Council on Bill 21-192, the “Medical Marijuana Laboratory Testing Amendment Act of 2015" and Bill 21-210 the “Medical Marijuana Reciprocity Amendment Act of 2015.”
These bills represent important steps towards modernizing the District of Columbia’s medical marijuana program. ASA supports both bills, but is seeking improvements to B21-210 to ensure adequate supply and address technical issues. ASA also asked the Council to add delivery and civil protections to the bill.
The Medical Marijuana Laboratory Testing Amendment Act would allow DC to finally have laboratory testing by third parties. This is an essential step for patients to have the confidence they deserve in their medicine. The Medical Marijuana Reciprocity Amendment Act of 2015 is also an important reform, however with the dramatic shortages of medicine in DC’s current system allowing out of the District patients access to the dispensaries would be problematic until those shortages are addressed.
ASA is also asking the Council to move on protecting medical marijuana patients from civil discrimination. In the past few years we’ve seen genuinely tragic instances of parents losing custody of their children, workers being fired and even people being denied organ transplants for no other reason than their doctor recommend medical marijuana usage. These problems can be avoided in the District if the Council acts now instead of waiting.
Please ask your Council Member to support Bill 21-192 and Bill 21-210 with our requested changes. Click here to locate your council member.
Read our full testimony here: